Medindia

X

3SBio Inc. to Present at the Goldman Sachs Twenty-Ninth Annual Global Healthcare Conference

Thursday, May 29, 2008 General News J E 4
Advertisement
SHENYANG, China, May 28 3SBio Inc.(Nasdaq: SSRX), a leading biotechnology company focused on researching,developing, manufacturing and marketing biopharmaceutical products primarilyin China, announces that David Chen, Chief Operating Officer, and Kevin Teo,Chief Financial Officer will present at the Goldman Sachs Twenty-Ninth AnnualGlobal Healthcare Conference in Dana Point, California on Tuesday, June 10,2008 at 1:20 PM (Pacific Time).

The presentation will be webcast live and can be accessed on the Webcastssection of the investors page of the 3SBio website at:http://bbs.3sbio.com/en/News/ShowInfo_nnn6.aspx?ID=65 . A replay of thepresentation and accompanying slides will be available on the 3SBio websitefor a period of 30 days.

About 3SBio Inc.

3SBio Inc. is a leading, fully integrated biotechnology company focused onresearching, developing, manufacturing and marketing biopharmaceuticalproducts, primarily in China.

For more information, please visit 3SBio on the web at:http://www.3sbio.com .For more information, please contact: Investor Contact: Kevin Teo, CFO 3SBio Inc. Tel: +86-24-2581-1820 Investor Relations (US): Mahmoud Siddig Taylor Rafferty Tel: +1-212-889-4350 Investor Relations (HK): Ruby Yim Taylor Rafferty Tel: +852-3196-3712 Media Contact: Jason Marshall Taylor Rafferty Tel: +1-212-889-4350

SOURCE 3SBio Inc.
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Orphan Therapeutics Announces Initiation of Rollin...
S
Shareholders Demand Philip Morris USA Stop Interfe...